|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
84,924,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. Co. is developing a pipeline of product candidates with an initial focus on validated oncology targets. Co. has two primary product candidates: ZN-c3, an inhibitor of Wee1, a protein tyrosine kinase, and ZN-c5, an oral selective estrogen receptor degrader. Co.'s other clinical product candidates include ZN-d5, a selective inhibitor of B-cell lymphoma 2 and ZN-e4, an irreversible inhibitor of mutant epidermal growth factor receptor.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
22,000 |
22,000 |
Total Buy Value |
$0 |
$0 |
$219,391 |
$219,391 |
Total People Bought |
0 |
0 |
2 |
2 |
Total Buy Transactions |
0 |
0 |
2 |
2 |
Total Shares Sold |
12,953 |
41,815 |
68,993 |
346,626 |
Total Sell Value |
$157,325 |
$490,017 |
$1,047,834 |
$8,137,870 |
Total People Sold |
2 |
5 |
8 |
8 |
Total Sell Transactions |
2 |
8 |
12 |
35 |
End Date |
2024-04-07 |
2024-01-05 |
2023-07-07 |
2022-07-07 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Epperly Melissa B, |
Chief Financial Officer |
|
2020-12-07 |
4 |
AS |
$50.84 |
$345,963 |
D/D |
(6,464) |
277,679 |
|
- |
|
Bunker Kevin D. |
Chief Operating Officer |
|
2020-12-07 |
4 |
AS |
$50.84 |
$582,954 |
D/D |
(10,892) |
1,053,880 |
|
- |
|
Gallagher Cam |
Director |
|
2020-12-07 |
4 |
AS |
$50.84 |
$358,166 |
D/D |
(6,692) |
602,765 |
|
- |
|
Sun Anthony Y |
President & CEO |
|
2020-12-07 |
4 |
AS |
$50.84 |
$1,905,682 |
D/D |
(35,606) |
2,017,605 |
|
- |
|
Epperly Melissa B, |
Chief Financial Officer |
|
2020-12-04 |
4 |
AS |
$50.76 |
$368,097 |
D/D |
(7,220) |
284,143 |
|
- |
|
Bunker Kevin D. |
Chief Operating Officer |
|
2020-12-04 |
4 |
AS |
$50.76 |
$620,207 |
D/D |
(12,165) |
1,064,772 |
|
- |
|
Gallagher Cam |
Director |
|
2020-12-04 |
4 |
AS |
$50.76 |
$381,047 |
D/D |
(7,474) |
609,457 |
|
- |
|
Sun Anthony Y |
President & CEO |
|
2020-12-04 |
4 |
AS |
$50.76 |
$2,027,540 |
D/D |
(39,769) |
2,053,211 |
|
- |
|
Gallagher Cam |
Director |
|
2020-12-02 |
4 |
AS |
$49.82 |
$514,334 |
D/D |
(10,000) |
616,931 |
|
- |
|
Epperly Melissa B, |
Chief Financial Officer |
|
2020-12-02 |
4 |
AS |
$50.34 |
$158,681 |
D/D |
(3,083) |
291,363 |
|
- |
|
Johnson David Michael |
Director |
|
2020-12-02 |
4 |
AS |
$49.80 |
$662,747 |
D/D |
(12,896) |
101,752 |
|
- |
|
Sun Anthony Y |
President & CEO |
|
2020-12-02 |
4 |
AS |
$49.79 |
$1,377,344 |
D/D |
(26,794) |
2,092,980 |
|
- |
|
Bunker Kevin D. |
Chief Operating Officer |
|
2020-12-01 |
4 |
AS |
$49.68 |
$445,883 |
I/I |
(8,420) |
84,200 |
|
- |
|
Shabet Rose Sharon |
10% Owner |
|
2020-12-01 |
4 |
S |
$50.50 |
$25,250,000 |
I/I |
(500,000) |
3,943,284 |
|
- |
|
Sun Anthony Y |
President & CEO |
|
2020-11-24 |
4 |
AS |
$46.21 |
$528,844 |
D/D |
(11,386) |
2,119,774 |
|
- |
|
Epperly Melissa B, |
Chief Financial Officer |
|
2020-11-23 |
4 |
AS |
$46.51 |
$143,614 |
D/D |
(3,083) |
294,446 |
|
- |
|
Bunker Kevin D. |
Chief Operating Officer |
|
2020-11-23 |
4 |
AS |
$46.28 |
$392,179 |
I/I |
(8,425) |
92,620 |
|
- |
|
Bunker Kevin D. |
Chief Operating Officer |
|
2020-11-23 |
4 |
GA |
$0.00 |
$0 |
I/I |
101,045 |
101,045 |
|
- |
|
Bunker Kevin D. |
Chief Operating Officer |
|
2020-11-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
101,045 |
1,076,937 |
|
- |
|
Sun Anthony Y |
President & CEO |
|
2020-11-23 |
4 |
AS |
$46.45 |
$716,920 |
D/D |
(15,408) |
2,131,160 |
|
- |
|
Gallagher Cam |
Director |
|
2020-11-23 |
4 |
AS |
$46.44 |
$465,381 |
D/D |
(10,000) |
626,931 |
|
- |
|
Sun Anthony Y |
President & CEO |
|
2020-11-22 |
4 |
GA |
$0.00 |
$0 |
I/I |
213,600 |
213,600 |
|
- |
|
Sun Anthony Y |
President & CEO |
|
2020-11-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
213,600 |
1,804,005 |
|
- |
|
Recurium Equity, Llc |
10% Owner |
|
2020-10-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,147,940) |
14,990 |
|
- |
|
Johnson David Michael |
Director |
|
2020-04-07 |
4 |
AB |
$18.00 |
$72,000 |
D/D |
4,000 |
114,648 |
|
- |
|
243 Records found
|
|
Page 9 of 10 |
|
|